Related Experiment Video
Updated: May 8, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Surgery for nonsmall cell lung cancer.
1Dept of Thoracic Surgery, King's College, London, UK. loic.lang-lazdunski@gstt.nhs.uk
Summary
Surgery is the primary cure for early-stage lung cancer. Advances in minimally invasive techniques and improved perioperative care enhance outcomes, while new therapies offer alternatives for non-surgical candidates.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Surgery is the best curative option for early-stage lung cancer (Stages I and II).
- Minimally invasive techniques enable lung resections in elderly patients and those with comorbidities.
- New ablative and radiotherapy techniques are emerging as alternatives for non-surgical candidates.
Purpose of the Study:
- To review the current role of surgery in lung cancer management.
- To discuss advancements in surgical techniques and perioperative care.
- To explore alternative treatments and future directions in lung cancer therapy.
Main Methods:
- Review of current literature and clinical practice guidelines.
- Analysis of advancements in surgical, radiological, and oncological treatments.
- Evaluation of data from large randomized trials and surgical databases.
Main Results:
- Significant reduction in perioperative mortality and improved complication management.
- Advancements in imaging and staging reduce futile thoracotomies.
- Established roles for neoadjuvant, induction, and adjuvant therapies in multimodality treatment.
Conclusions:
- Surgery remains crucial for early-stage and selected advanced-stage lung cancer.
- Minimally invasive approaches and new therapies improve patient selection and outcomes.
- Early detection, targeted therapies, and biomarker development are key for future prognosis improvement.
